Michael Graves

Michael Graves

Chief Executive Officer at EAGLE PHARMACEUTICALS, INC.

Net worth: 54 286 $ as of 30/03/2024

61 year
Health Technology
Consumer Services

Profile

Michael Graves is currently the Executive Chairman & Chief Executive Officer at Eagle Pharmaceuticals, Inc., the Executive Chairman at Nanocopoeia, Inc., and the Director at RiboCor, Inc. Previously, he served as the President & Chief Executive Officer at Paddock Laboratories, Inc., the President-Generic Products Division at Endo Generics Holdings, Inc., and the President-Generic Products Division at Par Pharmaceutical, Inc. He obtained his undergraduate degree from the State University of New York at Buffalo.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/02/2024 10,360 ( 0.08% ) 54 286 $ 30/03/2024

Michael Graves active positions

CompaniesPositionStart
EAGLE PHARMACEUTICALS, INC. Chief Executive Officer 26/11/2023
Director/Board Member 31/12/2011
Chairman 30/11/2011
All active positions of Michael Graves

Former positions of Michael Graves

CompaniesPositionEnd
Chief Executive Officer 30/06/2011
PAR PHARMACEUTICAL COMPANIES, INC. Corporate Officer/Principal 14/11/2006
Corporate Officer/Principal 31/12/2005
See the detail of Michael Graves's experience

Training of Michael Graves

State University of New York at Buffalo Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Graves's experience

Connections

66

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
EAGLE PHARMACEUTICALS, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Michael Graves